Evidence of the symptomatic and structural efficacy of methotrexate in daily practice as the first disease-modifying drug in rheumatoid arthritis despite its suboptimal use: results from the ESPOIR early synovitis cohort.
Data and Resources
Additional Info
| Field | Value |
|---|---|
| Source | ISSN: 1462-0324 |
| Author | Gaujoux-Viala, Cécile, Paternotte, Simon, Combe, Bernard, Dougados, Maxime, Saraux, Alain |
| Maintainer | CCSD |
| Last Updated | May 14, 2026, 08:41 (UTC) |
| Created | May 14, 2026, 08:41 (UTC) |
| Identifier | hal-00790803 |
| Language | en |
| contributor | CHU Pitié-Salpêtrière [AP-HP] ; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU) |
| creator | Gaujoux-Viala, Cécile |
| date | 2012-09-14T00:00:00 |
| harvest_object_id | 24425e2c-ab03-44e0-9688-c492155493e4 |
| harvest_source_id | 3374d638-d20b-4672-ba96-a23232d55657 |
| harvest_source_title | test moissonnage SELUNE |
| metadata_modified | 2026-02-07T00:00:00 |
| relation | info:eu-repo/semantics/altIdentifier/doi/10.1093/rheumatology/kes135 |
| set_spec | type:ART |